Hancock Whitney’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Hancock Whitney’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35,191	Closed	-$969K	–	846
2021 Q2	$969K	Buy	35,191 +460	+1%	+$9.04K	0.03%	413
2021 Q1	$573K	Buy	34,731 +10,682	+44%	+$243K	0.02%	509
2020 Q4	$443K	Buy	+24,049	New	+$430K	0.01%	560

Hancock Whitney's TBIO Position: Q3 2021 in Review

Hancock Whitney sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 35,191 shares — an estimated $969K sold.

Hancock Whitney first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $969K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Hancock Whitney reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Hancock Whitney sold 35,191 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $969K.
Hancock Whitney first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Hancock Whitney's Translate Bio, Inc. Common Stock position peaked at $969K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.